Scientific Publications
Explore our latest peer-reviewed publications co-authored by JMF staff in top-tier immunology journals, showcasing updates and advancements in Primary Immunodeficiency research.
Research Leadership & Collaboration
Over 25 years, JMF has fostered groundbreaking research in Primary Immunodeficiency, co-authoring 460+ publications with leading institutions worldwide. Explore our research topics, publication growth, and collaboration network demonstrating sustained commitment to advancing PI science.
Top Research Topics
JMF-affiliated research spans 15+ topics across Treatment, Immunology, Diagnosis, Genetics, and Clinical domains. IVIG Therapy and Antibody Deficiency lead with 50+ publications each.
Loading chart...
Publication Volume Growth
Annual publication output has grown from 12 papers in 2000 to 156 in 2025, demonstrating 18% compound annual growth rate and achieving 460+ cumulative publications.
Loading chart...
Institutional Collaboration Network
JMF serves as the central hub connecting 9 major academic and clinical institutions, including NIH, Johns Hopkins, Harvard Medical School, and Boston Children's Hospital. Node sizes reflect publication output; link thickness shows collaboration strength.
Loading network diagram...
2024
Validating inborn error of immunity prevalence and risk with nationally representative electronic health record data
- Nicholas L Rider, Ahuva Truxton, Tracy Ohrt, Irene Margolin-Katz, Mary Horan, Harold Shin, Roger Davila, Vanessa Tenembaum, Jessica Quinn, Vicki Modell, Fred Modell, Jordan S Orange, Almut Branner, Cynthia Senerchia
2022
A Validated Artificial Intelligence-Based Pipeline for Population-Wide Primary Immunodeficiency Screening
- Nicholas L. Rider, DO, Michael Coffey, BBA, Ashok Kurian, MBA, Jessica Quinn, MPH, Jordan S. Orange, MD, PhD, Vicki Modell, Fred Modell
Global Expansion of Jeffrey’s Insights: Jeffrey Modell Foundation’s Genetic Sequencing Program for Primary Immunodeficiency
- Quinn, J., Modell, V., Aradhya S., Johnson B., Orange, J.S., Poll, S., Modell, F.
Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network.
- Quinn, J., Modell, V., Orange, J.S., Modell, F.
2020
Jeffrey’s insights: Jeffrey Modell Foundation’s global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment.
- Quinn J, Modell V, Holle J, Truty R, Aradhya S, Johnson B, Orange J, Modell F.
The case for severe combined immunodeficiency (SCID) and T cell lymphopenia newborn screening: saving lives…one at a time
- Quinn J, Orange J, Modell V, Modell F.
2019
Calculation of a Primary Immunodeficiency "Risk Vital Sign" via Population-Wide Analysis of Claims Data to Aid in Clinical Decision Support.
- Rider N, Miao D, Dodds M, Modell V, Modell F, Quinn J, Schwarzwald H, Orange J.
2018
2017
Patients with Primary immunodeficiencies are a reservoir of Poliovirus and a risk to Polio eradication.
- Aghamohammadi A, Abolhassani H, Quinn J, Modell F, Modell V, The JMF Centers Network Investigators and Study Collaborators, et al.
Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement.
- Modell V, Quinn J, Ginsberg G, Gladue R, Orange J, Modell F.
2016
Primary Immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.
- Modell V, Quinn J, Orange J, Notarangelo LD, Modell F.
2015
Genetics of SCID
- Cossu, Fausto
2014
Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.
- Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD.
2013
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: The Primary Immune Deficiency Treatment Consortium experience.
- Shearer WT, Dunn E, Notarangelo LD, Dvorak CC, Puck JM, Logan BR, Griffith LM, Kohn DB, O'Reilly RJ, Fleisher TA, Pai SY, Martinez CA, Buckley RH, Cowan MJ.
Chronic granulomatous disease: two decades of experience from a tertiary care centre in north west India.
- Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, Sehgal S, Vaiphei K, Kamae C, Honma K, Nakagawa N, Imai K, Nonoyama S, Oshima K, Mitsuiki N, Ohara O, Chan KW, Lau YL.
Attending to Warning Signs of Primary Immunodeficiency Diseases across the range of clinical practice.
- Costa-Carvalho BT, Grumach AS, Franco JL, Espinosa-Rosales FJ, Leiva LE, King A, Porras O, Bezrodnik L, Oleastro M, Sorensen RU, Condino-Neto A.
A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside.
- Roifman CM, Seger R, Tang ML, Puck JM, Chapel H, Notarangelo LD, Casanova JL.